<DOC>
	<DOCNO>NCT00723736</DOCNO>
	<brief_summary>The objective non-interventional study evaluate safety Aerius syrup pediatric patient age 1-5 year old allergic rhinitis chronic idiopathic uticaria . The patient receive 2.5 ml ( 1.25 mg ) daily .</brief_summary>
	<brief_title>Safety Aerius Syrup Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis Chronic Idiopathic Urticaria ( Study P04446AM1 ) ( COMPLETED )</brief_title>
	<detailed_description>Pediatric patient age 1-5 year</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Patients allergic rhinitis chronic idiopathic urticaria Aged 15 year old Caregiver 's consent participate Healthy individual Younger old 15 year old age range</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>